Patterns and clinical relevance of antibody responses during adalimumab therapy

RDF 

 
This item is provided by the institution :
Hellenic Society of Gastroenterology
Repository :
Annals of Gastroenterology
see item page
in the web site of the repository *
share



Semantic enrichment/homogenization by EKT

2010 (EN)
Patterns and clinical relevance of antibody responses during adalimumab therapy (EN)

Katsanos, K.H.
Vagias, I.
Tsianos, V.
Tsianos, E.V.

All biologic therapies have the potential to induce immunogenicity. Homology reduces antigenicity, but ‘humanization' does not equate with homology and human antibodies may be also immunogenic. Despite of its proved efficacy in Crohn's disease patients, adalimumab carries the potential of molecule-specific toxicities which may be expressed with several types of antibody responses, and which are usually divided as allergic, autoimmunity and immunogenicity phenomena. (EN)

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

Ελληνική Γαστροεντερολογική Εταιρία (EL)
Hellenic Gastroenterologiki Company (EN)

2010-07-09


Hellenic Society of Gastroenterology (EN)

1792-7463
1108-7471
Annals of Gastroenterology; Volume 23, No 3 (2010); 165 - 171 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)